<DOC>
	<DOCNO>NCT02057874</DOCNO>
	<brief_summary>This pilot clinical trial examines well different image biomarkers acquire use 3-Telsa magnetic resonance imaging ( MRI ) method perform determine treatment response transarterial chemoembolization ( TACE ) patient hepatocellular carcinoma . Compared conventional imaging , multi-parametric 3-Tesla MRI offer ability quantitatively measure tissue structural , functional , cellular , molecular property , provide robust , clinically relevant method assess cancer response therapy .</brief_summary>
	<brief_title>3-Tesla MRI Response TACE HCC ( Liver Cancer )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Subjects must sign institutional review board ( IRB ) approve informed consent document Subjects must verify unresectable hepatocellular carcinoma ( HCC ) , diagnose basis clinical image criteria Subjects must classify TNM stage I , II , III ; alternatively , subject may classify Barcelona Clinic Liver Cancer ( BCLC ) stage A B Subjects must schedule undergo transarterial chemoembolization ( TACE ) Subjects must least 1 lesion target TACE &gt; 2 cm long crosssectional ( axial plane ) diameter Subjects must satisfy one follow condition pertain eligibility undergo orthotopic liver transplantation ( OLT ) : HCC within Milan Criteria , i.e. , TACE indicate `` bridge '' OLT ( Group I ) ; HCC outside Milan Criteria , i.e. , TACE indicate mean `` downstaging '' transplant eligibility ( Group II ) Subjects receive prior treatment HCC ( prior surgical procedure relate HCC allow ) Subjects undergone prior radioembolization Subjects central venous line Subjects type biomedical implant , device and/or ferromagnetic material displace , perturb , otherwise malfunction due mechanical , electronic , magnetic mean ; item may include : Metallic fragment shrapnel ( war wound ) Cerebral aneurysm clip , biopsy marker clip Vascular access port ( use intravenous chemotherapy ) Cochlear implant , pacemaker , neurostimulators , biostimulators , electronic infusion pump **Implanted material verify rat `` magnetic resonance [ MR ] Safe '' `` MR Conditional 6 '' allow study Creatinine &gt; = 1.5 time upper limit normal Estimated glomerular filtration rate ( eGFR ) &lt; 30 mL/min Subjects pregnant nursing Subjects past allergic adverse reaction intravenous injection MagnevistÂ® ( gadopentetate dimeglumine ) gadoliniumcontaining contrast agent Subjects exhibit noticeable anxiety , claustrophobia , vertigo move scanner Subjects incapable give informed write consent , follow reason : Inability adhere experimental protocol reason Inability communicate research team Mental disability , alter mental status , confusion , psychiatric disorder Prisoners others susceptible coercion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>